Signet Healthcare Partners provides growth capital to commercial-stage healthcare companies that are revenue-generating or preparing for commercial launch, with a primary focus on specialty pharmaceuticals, medical devices, diagnostics, and pharmaceutical services.
About Signet Healthcare Partners
Signet Healthcare Partners is a New York-based growth equity firm focused exclusively on commercial-stage healthcare companies, with a portfolio that spans pharmaceutical services, specialty pharmacy, healthcare technology, and selectively medical products. Stage focus is growth equity and later, with checks typically in the $10M to $30M range and a preference for revenue-generating companies with clear commercial momentum. Healthcare exposure is exclusive and tied to mature commercial businesses rather than early-stage venture bets. Physician founders running revenue-generating healthcare services, specialty pharmacy, or commercial-stage healthcare technology businesses are the right profile. Founders running pre-revenue companies, capital-intensive biotech, early-stage device companies without commercial validation, or seed-stage software bets should pitch elsewhere; this is not a venture firm. Geographic posture is US-led with selective international deal capacity. The realistic entry path is engagement through investment banking advisors, a co-investing growth fund, or a healthcare services operator in the firm’s network; the partners run an institutional process anchored on commercial diligence and financial discipline. Founders should arrive with multi-year financial history, defensible commercial traction, and a clear growth narrative supported by clean financials. Treat Signet Healthcare Partners as a growth equity specialist for mature commercial healthcare businesses, not as an early-stage venture option for the typical physician AI founder.
Founder reviews
Other portfolio companies
Companies in Signet Healthcare Partners's portfolio not currently in our directory.
- Paragonix Technologies · 2023
- RK Pharma · 2019
- PainTEQ · 2025
- NorthX Biologics · 2025
- Ascendia Pharmaceuticals · 2021
- Altasciences · 2021
- Juno Pharmaceuticals · 2022
- SMART Medical Systems · 2018
- Leading Pharma · 2017
Team
Pitch / review this investor
Have you raised from Signet Healthcare Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).